Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

IntraBio Inc

Clinical trials sponsored by IntraBio Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a simple amino acid ease rare brain disorders? Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Terminated 1

Experimental drug shows promise for rare genetic disorder

Disease control Stopped early

This Phase II trial tested a drug called N-Acetyl-L-Leucine (IB1001) in 17 people with Ataxia-Telangiectasia, a rare genetic disease that affects movement and immunity. The study aimed to see if the drug could improve symptoms and slow the disease over time. The trial was termina…

Phase 2 • Sponsor: IntraBio Inc • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC